|
|
||||||||
Division of Nephrology, University of Maryland School of Medicine, Baltimore, Maryland 21201-1595; and Division of Nephrology, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey, Pennsylvania 17033
| |
ABSTRACT |
|---|
|
|
|---|
Outer medullary descending vasa recta
(OMDVR) were dissected from the outer medullary vascular bundles of
young rats, perfused in vitro, and loaded with fura 2 for
measurement of intracellular calcium concentration
([Ca2+]i)
by fluorescent ratio imaging. Fluorescent video images revealed that
fura 2 selectively loads into endothelial cells but not pericytes. Bradykinin (BK), at concentrations
>10
11 M, elicited an
increase in
[Ca2+]i
from baseline values in the range from 50 to 100 nM to peak values of
600-800 nM followed by a sustained plateau of 150-250 nM. The vasopressin
V1-receptor agonist
[Phe2,Ile3,Orn8]vasopressin
constricted OMDVR but yielded no observable
[Ca2+]i
response, a finding that is consistent with an endothelial cell origin
for the fura 2 fluorescent signal. The BK
[Ca2+]i
response was blocked by the selective BK
B2-receptor antagonists D-Arg-[Hyp3,Thi5,8, D-Phe7]BK
and
D-Arg-[Hyp3,D-Phe7,Leu8]BK
but not the B1 antagonist
des-Arg9-[Leu8]BK.
BK vasodilated microperfused OMDVR that had been preconstricted with
10
8 M angiotensin II. We
conclude that the
[Ca2+]i
response of OMDVR endothelia can be selectively studied with fura 2, that BK increases endothelial
[Ca2+]i
via the B2 receptor, and that BK
can vasodilate descending vasa recta.
microcirculation; microperfusion; renal medulla; receptor; calcium
| |
INTRODUCTION |
|---|
|
|
|---|
BRADYKININ (BK) and Lys-BK (kallidin) are peptide hormones released on cleavage of their high (HMW)- or low (LMW)-molecular-weight kininogen precursors. HMW and LMW kininogens are enzymatically degraded by the action of kallikreins, serine proteases that exist either in the circulation as plasma kallikreins or in various organs as tissue kallikreins. HMW kininogen is readily cleaved by plasma kallikrein, whereas LMW kininogen is a poorer substrate for this enzyme. In contrast, tissue kallikreins release bioactive products from either precursor (4, 11).
The kidney is a site for LMW kininogen synthesis, principally in epithelial cells of the distal nephron including the cortical and medullary collecting ducts (9). A recent study using sensitive reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemical staining with antibodies specific for kininogens demonstrated expression of the HMW as well as the LMW kininogen in these locations (11). Interestingly, collecting duct cells expressing kininogens lie adjacent to those producing tissue kallikrein, suggesting that local production of BK and kallidin might occur in the renal medulla to enable regulation of various processes by these hormones (9, 12, 13, 21, 27, 30, 31).
Although BK and kallidin are often thought of as inflammatory mediators (4, 11, 18), there is substantial evidence that they act as paracrine regulators of renal medullary sodium reabsorption and blood flow (15, 24, 25). Outer medullary descending vasa recta (OMDVR) are vasoactive branches of juxtamedullary efferent arterioles through which the majority of blood flow to the medulla occurs. We hypothesize that BK partially exerts its actions in the renal medulla through receptor-operated calcium signaling in descending vasa recta endothelia. With the use of microdissected, in vitro perfused OMDVR from rats, we show that kinins increase endothelial intracellular calcium concentration ([Ca2+]i) and that BK dilates vessels preconstricted with angiotensin II (ANG II).
| |
METHODS |
|---|
|
|
|---|
In vitro microperfusion. Microperfusion of OMDVR dissected from vascular bundles in the inner stripe of the outer medulla has been described in detail (19, 20). Vessels were perfused on the stage of an inverted microscope (Nikon Diaphot) using apparatus from Instruments Technology and Machinery (San Antonio, TX). In these studies, an oil immersion objective with short working distance was required to obtain fluorescent videoimages, making temperature near the specimen difficult to control. To overcome this obstacle, we custom built perfusion chambers that permit rapid exchange of the bath without deviation of temperature from 37°C. Bathing buffer is warmed immediately upstream of the chamber under feedback control (CN9111A, Omega Engineering). The thermocouple probe of a second, identical controller is located in the narrow inlet region of the chamber next to the perfused vessel. Heating from the controllers is separately applied by passing current through nickel-chromium wires, one surrounding the inlet tubing upstream of the chamber and another embedded in the acrylic around the inlet region.
Vasa recta were dissected from the kidneys of 70- to 150-g Sprague-Dawley rats (Harlan Sprague Dawley) at 4°C. These animals were given an intraperitoneal bolus injection of thiopental sodium (50 mg/kg body wt) before removal of the kidneys. OMDVR, dissected from vascular bundles of the inner stripe, are readily recognized under the dissecting stereomicroscope by their small size and the irregular cell spacing along their walls (19). Microperfusion pipettes were 4-6 µm (inner diameter). Holding pipettes were 13-15 µm (inner diameter) with constrictions of ~6-9 µm. Collection pipettes were typically ~10 µm at the inlet. The following buffer was used for dissection, bath, and perfusate (in mM): 5 N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid, 140 NaCl, 10 sodium acetate, 5 KCl, 1.2 MgCl2, 1.71 Na2HPO4, 0.29 NaH2PO4, 1 CaCl2, 5 alanine, and 5 glucose and 0.5 g/dl albumin, pH 7.4.Videomicroscopy and measurement of vessel diameters. To measure the effects of vasoactive substances on OMDVR diameters, microperfusion experiments were captured on videotape. The inverted microscope is equipped with a 0/100% beam splitter and a side port with a C mount for attachment of a video camera (Panasonic WV-BL90). Experiments were recorded on a Panasonic model AG 1960 videocassette recorder equipped with a microphone for voice recording. Experiments were played back, and diameters were measured from the video screen with calipers (20, 26).
In this study, changes in vessel outer diameter are expressed as percent constriction defined in terms of the basal (Do) and experimental (D) diameters by
|
(1) |
Fluorescent imaging system. A digital fluorescent imaging system was employed to measure [Ca2+]i of fura 2-loaded OMDVR. Light for excitation of fura 2 was provided from a 75-W xenon arc lamp (PTI, South Brunswick, NJ) directed through a computer-controlled shutter (Uniblitz, Rochester, NY). The excitation wavelength was isolated using 340HT15 and 380HT15 bandpass filters (Omega Optical, Brattleboro, VT) mounted on a solenoid and computer syncronized for image acquisition. OMDVR were observed through a 1.3 NA Nikon CF fluor ×40 oil immersion objective. Fluorescence was monitored at 510 nm and directed to a charge-coupled device (CCD) camera (Loral, Milpitas, CA) equipped with an 18-mm image intensifier (Varo, Garland, TX) via a 0/100% beam splitter. The automatic gain control of the CCD camera was disabled. The intensifier provides a constant gain of 20,000 but has an automatic cutoff to protect against excessive illumination. Output of the CCD camera was captured with a 4-MB GRB silicon video MUX frame grabber (Epix, Northbrook, IL) with a resolution of 8 bits/pixel. Digitized frames were displayed in real time on a color monitor as a pseudocolor image.
For measurement of [Ca2+]i, fura 2-loaded OMDVR were briefly excited at 340 and 380 nm at 6- to 10-s intervals between which the shutter was closed to protect against photobleaching (3). Eight to thirty-two videoframes were averaged and stored at each wavelength. Background-subtracted 340 nm-to-380 nm ratio images (R340/380) were calculated for conversion to the equivalent [Ca2+]i image. For analysis, the entire microvessel rather than areas of maximal [Ca2+]i change was chosen as the "region of interest." Thus data reported herein indicate an average response for the microvessel as a whole. The resolution of the ratio images is limited by the poor two-point discrimination of the image intensifier. High-resolution images were obtained using a cooled CCD camera (Spectrasource MCD600S, Westlake Village, CA) that permits timed exposure of a cooled (
30°C)
sensor head (Kodak KAF0400-0) to capture 16-bit images. Sequential
white light and fluorescent images were captured using 0.1- to 0.2-s
and 60- to 120-s exposures, respectively.
Measurement of [Ca2+]i in fura 2-loaded OMDVR. OMDVR were loaded with the Ca2+-sensitive fluorescent indicator fura 2 by exposure to bath containing 2 µM fura 2-acetoxymethyl ester (fura 2-AM; Molecular Probes, Eugene, OR). At the time the bath was exchanged to contain fura 2-AM, the feedback controller was turned on, gradually warming the vessel to 37°C over ~5 min. A total fura 2-AM exposure time of 15 min was consistently used to load OMDVR. Stock fura 2-AM was stored frozen in anhydrous dimethyl sulfoxide (DMSO) at a concentration of 1 mM.
R340/380 was converted to [Ca2+]i according to
|
(2) |
-aminoethyl
ether)-N,N,N',N'-tetraacetic acid (EGTA), respectively, along with 10 µM 4-bromo-A-23187 calcium ionophore (Sigma).
There are a number of pitfalls to be avoided in the measurement of
[Ca2+]i
with a digital imaging system (23). First, to avoid saturation of the
8-bit (0-28 gray scale)
images (clipping), the xenon lamp was adjusted to yield a mean emission
intensity of the 340-nm image
(f340) just below midrange. As
[Ca2+]i
increased after exposure to kinins,
f340 (and
R340/380) increased while
f380 decreased so that clipping
was avoided at each excitation wavelength. A second potential problem
concerns the intensifier cutoff safety feature. If this feature is
activated by excess incident light, erroneous measurement of
R340/380 results. To verify that these factors were not a problem at the fluorescent light
levels emitted by fura 2-loaded OMDVR, the ability of the imaging
system to measure
[Ca2+] in a similar
geometry was examined. The pentapotassium salt of fura 2 (2 µM) was
added to CaEGTA buffers and perfused through the lumen of a
15-µm-diameter glass pipette. The latter was created by drawing out a
perfusion pipette and bending it to a 30° angle to lie parallel to
the microscope stage. For a CaEGTA buffer
|
(3) |
|
(4) |
Linearity
of the imaging system is demonstrated for
[CaEGTA]/[EGTA] buffers
(Eq. 4) at room temperature and at
37°C in Fig. 1. Appropriate linearity
was verified.
|
Reagents.
BK, kallidin, and related receptor subtype-specific agonists and
antagonists (Table 1) and ANG II were
purchased from Sigma. The
V1-receptor agonist
[Phe2,Ile3,Orn8]vasopressin
(V1AG) was obtained from Peninsula (Belmont, CA). These agents
were dissolved in water at
10
3-10
5
M and stored frozen at
20°C. Aliquots of 25-100 µl
were thawed on the day of the experiment. The excess was discarded at
the end of each day. 4-Bromo-A-23187 calcium ionophore was dissolved in
ethanol at 10 mM, and fura 2-AM was stored frozen in anhydrous DMSO at
a concentration of 1 mM.
|
Statistical analysis. Experimental results are reported as means ± SE. Statistical comparisons used paired t-test, unpaired t-test, or repeated-measures analysis of variance (ANOVA) as appropriate. For ANOVA, significance was determined by the Student-Newman-Keuls test.
| |
RESULTS |
|---|
|
|
|---|
Localization of fura 2 signal.
The descending vasa recta wall is made up of two cell types,
endothelial cells, which line the lumen, and smooth muscle remnants called pericytes, the cell bodies of which protrude from the abluminal side (19, 20). White light and fluorescent micrographs were obtained
with the Spectrasource cooled CCD camera in fura 2-loaded OMDVR
(N = 8). Three representative
reproductions are shown in Fig. 2.
Endothelial cells and pericytes can be readily discerned from the
high-magnification white light images in the left panels of Fig. 2. For
comparison, corresponding fluorescent images captured at 510 nm using
340-nm excitation are shown in the right panels of Fig. 2. The pattern
of fluorescence indicates an endothelial origin with little or no
contribution from pericytes. Pseudocolor 340-nm, 380-nm, and 340/380
images of fura 2-loaded OMDVR obtained with the intensified CCD camera
before and after application of BK
(10
8 M) are shown in Fig.
3. Again, a pattern consistent with an
endothelial origin is apparent, although the definition of the images
is inherently limited by the relatively poor resolution of the image
intensifier.
|
|
Response of fura 2-loaded OMDVR to BK and kallidin.
The typical response of OMDVR to abluminal BK exposure is shown in the
top panel of Fig. 4. Immediately after
application of BK,
[Ca2+]i
increased to yield peak and plateau phases. After removal of BK from
the bath,
[Ca2+]i
promptly returned to control levels. The concentration dependence of
the
[Ca2+]i
response to abluminal BK is shown in the bottom panel of Fig. 4.
Baseline
[Ca2+]i
was consistently in the range from 50 to 100 nM. BK, at concentrations >10
7 M, gave a maximal
response with mean peak values between 600 and 800 nM and a plateau
[Ca2+]i
of ~200 nM. The response of OMDVR to Lys-BK (kallidin) was similar to
that of BK (Fig. 5).
|
|
|
BK receptor subtype mediating calcium response.
To determine whether the calcium response to BK is mediated by
B1 or
B2 receptors, we performed a
series of experiments using subtype-specific inhibitors. For
convenience, the inhibitors, their actions, and the abbreviations we
use to define them are summarized in Table 1. The ability of the
inhibitors to raise [Ca2+]i
was examined (Table 2). When the
inhibitors were applied by themselves, no discernible peak
responses were seen but very small plateau increases in
[Ca2+]i
were found with
[Thi5,8,D-Phe7]BK
(TPBK) and
D-Arg-[Hyp3,Thi5,8,D-Phe7]BK
(HTPBK) {but not
D-Arg-[Hyp3,D-Phe7,Leu8]BK
(HPLBK)}, indicating some slight agonist activity for
these analogs. This is consistent with the actions of these
inhibitors at the B2 receptor as
summarized by Regoli et al. (22) and other authors (4, 11). The ability
of the inhibitors (10
6 M)
to block the
[Ca2+]i
response generated by 10
8 M
BK was examined in a separate series of experiments.
[Ca2+]i
was measured in fura 2-loaded, microperfused OMDVR, after which BK
along with vehicle or antagonist was added to the bath. The B1 blocker
des-Arg9-[Leu8]BK
(DALBK) had no significant effect on either the peak (Fig. 7, top)
or plateau (Fig. 7, bottom) phase of
the BK response. HTPBK and HPLBK are thought to be among the most
specific B2 blockers, with HPLBK
devoid of any agonist activity (22). Both HTPBK and HPLBK completely
blocked the
[Ca2+]i
response. The mixed agonist/antagonist TPBK reduced the peak response
but, on average, did not eliminate the plateau.
|
|
|
Vasomotor response of OMDVR to BK.
Anticipating that BK might behave as an endothelium-dependent
vasodilator, we tested its effects in vessels preconstricted with ANG
II. OMDVR were exposed to ANG II
(10
8 M) for 10 min after
which BK (10
7 M) was added
and then removed. As previously observed, ANG II constricted OMDVR
(19). A tendency for BK to reversibly dilate the vessels was
consistently observed but achieved statistical significance only when 1 or 100 µM L-arginine was
present in the bath throughout the experiment (Fig.
9).
|
| |
DISCUSSION |
|---|
|
|
|---|
Molecular machinery for generation of kinins is present in the renal medulla, suggesting local paracrine roles for these peptide hormones. Kallikreins, enzymes that release kinins from kininogen precursors, have been localized to connecting tubule of the rat, portions of the outer medulla, and collecting ducts of the papilla (9, 21, 30, 31). Recently, it has been established that both HMW kininogen and LMW kininogen are expressed in the distal nephron of the mammalian kidney. In the human, LMW kininogen has been demonstrated in the distal nephron in close proximity to cells that express tissue kallikrein (9). With the use of RT-PCR and specific antibodies, Hermann and colleagues (12) also verified that HMW kininogen exists in a similar distribution.
The presence of receptors on tubular and vascular elements of the kidney also favors a paracrine role for BK and kallidin (8). Kinins exert their actions via at least two receptor subtypes, B1 and B2. With the use of anti-peptide and anti-ligand antibodies, Figueroa and colleagues (8) showed that B2 receptors are expressed throughout the outer and inner medulla with cellular localization to a variety of nephron segments as well as afferent arteriolar smooth muscle. Information on the distribution of B1 receptors is limited; however, it is notable that mesangial cells, which have smooth muscle-like functions, express both B1 and B2 receptors, each of which mediates signaling through changes in [Ca2+]i (1, 2). Interestingly, activation of B2 receptors leads to afferent dilation but mesangial cell contraction (1).
Evidence exists to support a role for kinins to modulate blood flow to and sodium reabsorption by the renal medulla in normal and pathophysiological states. A 20% reduction of papillary blood flow during infusion of a kinin antagonist was found by Roman and colleagues (24). Enhancement of kinin activity through inhibition of kininases with enalaprilat or phosphoramidon increased both papillary blood flow and sodium excretion. Seino et al. (25) showed that injection of a competitive BK antagonist into Sprague-Dawley, Wistar-Kyoto, and spontaneously hypertensive rats (SHR) caused a reduction of blood pressure and renal blood flow. The blood pressure reduction in the SHR was less than that for the other groups, suggesting that some deficiencies of the kinin system can contribute to hypertension (25). A later study by Mattson and Cowley (15) supported a role for kinins as an endothelium-dependent vasodilator. Interstitial infusion of BK increased sodium and water excretion and enhanced papillary blood flow, an effect blocked by nitric oxide synthase inhibition.
In this study, we performed the first characterization of the role of kinins in modulation of the functions of descending vasa recta by measuring the [Ca2+]i response of fura 2-loaded, in vitro perfused OMDVR and the effect of BK on OMDVR vasomotor tone. This is also the first study to report [Ca2+]i responses in OMDVR. For this reason we sought to carefully determine which distribution of cell type(s) load fura 2 by cleavage of the acetoxymethyl ester. Surprisingly, comparison of white light and fluorescent video images of OMDVR indicates virtually no loading into pericytes (Figs. 2, 3). The reason for this is uncertain, but fura 2 is known to vary with respect to its loading by deesterification in different cell types (17), and some cells extrude fura 2 via the action of organic anion transporters (7). A second line of evidence favoring an endothelial cell origin for the fura 2 fluorescent signal is provided by the lack of a response of fura 2-loaded OMDVR to vasopressin analogs. Vasopressin contracts smooth muscle by binding to the V1 receptor, leading to activation of phospholipase C and the phosphatidylinositol pathway and an increase in [Ca2+]i (16). Application of V1AG to OMDVR leads to vasoconstriction but does not induce a fura 2 response (Fig. 6).
Blockade of B2 but not B1 receptors with subtype-specific antagonists eliminated the rise in [Ca2+]i induced by BK (Fig. 7), verifying the presence of a B2-type receptor on OMDVR endothelia. Because of the limitations of these methods, however, we cannot rule out the existence of B1 or B2 receptors on the pericytes that surround the OMDVR wall.
The observation that BK increases [Ca2+]i in endothelial cells led us to hypothesize that it would act as a vasodilator through release of nitric oxide, an effect previously observed in response to acetylcholine (32). BK-induced vasodilation of ANG II-preconstricted vessels was confirmed (Fig. 9). To achieve maximal vasodilation, it was necessary to have L-arginine in the bath because the tendency toward vasodilation did not achieve significance in the absence of L-arginine. A dependence of endothelial cells on external L-arginine for maximal nitric oxide generation has been observed in cell culture. Buckley et al. (5) increased [Ca2+]i in bovine aortic endothelial cells using BK or thapsigargin, an inhibitor of the intracellular calcium adenosinetriphosphatase responsible for intracellular calcium uptake and storage. Nitric oxide generation increased markedly when medium L-arginine concentration was increased from 0 to 1 µM, with no additional effect of increasing L-arginine further to 100 µM (5). This sensitivity of OMDVR vasodilation to external L-arginine might have physiological significance. Larson and Lockhart (14) found that L-arginine infusion restored the sensitivity of vasa recta blood flow to increases in perfusion pressure in SHR. The possibility that medullary interstitial L-arginine concentrations might be modulated through countercurrent exchange or multiplication is suggested by the work of Dantzler and Silbernagl (6), who showed carrier-mediated reabsorption of L-arginine from the loops of Henle.
In summary, we examined the
[Ca2+]i
in isolated, in vitro perfused OMDVR by fluorescent ratio imaging using
fura 2. BK and kallidin, which are mixed
B2- and
B1-receptor agonists, each
elicited an increase in
[Ca2+]i
from baseline values in the range from 50 to 100 nM to peak values of
600-800 nM followed by a sustained plateau of 150-250 nM. The
BK
[Ca2+]i
response was blocked by selective
B2-receptor antagonists but not a
B1 antagonist. BK vasodilated
microperfused OMDVR that had been preconstricted with
10
8 M ANG II. We conclude
that BK is a vasodilator of preconstricted OMDVR and that its actions
are probably mediated through release of endothelium-dependent
vasodilators in response to increases in
[Ca2+]i.
It is likely that kinins modulate renal medullary blood flow, at least
partially, through these effects on OMDVR.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grant DK-42495 and a Grant-in-Aid from the American Heart Association and was performed during the tenure of an Established Investigatorship of the American Heart Association to T. L. Pallone. T. L. Pallone is a Passano Physician-Scientist.
| |
FOOTNOTES |
|---|
Address for reprint requests: T. L. Pallone, Div. of Nephrology, N3W143, Univ. of Maryland at Baltimore, Baltimore, MD 21201-1595 (E-mail: tpallone{at}umppa1.ab.umd.edu).
Received 4 August 1997; accepted in final form 11 November 1997.
| |
REFERENCES |
|---|
|
|
|---|
1.
Bascands, J. L.,
C. Pecher,
G. Bompart,
J. Rakotoarivony,
J. L. Tack,
and
J. P. Girolami.
Bradykinin-induced in vitro contraction of rat mesangial cells via a B2 receptor type.
Am. J. Physiol.
267 (Renal Fluid Electrolyte Physiol. 36):
F871-F878,
1994
2.
Bascands, J. L.,
C. Pecher,
S. Rouaud,
C. Emond,
J. L. Tack,
M. J. Bastie,
R. Burch,
D. Regoli,
and
J. P. Girolami.
Evidence for existence of two distinct bradykinin receptors on rat mesangial cells.
Am. J. Physiol.
264 (Renal Fluid Electrolyte Physiol. 33):
F548-F556,
1993
3.
Becker, P. L.,
and
F. S. Fay.
Photobleaching of fura-2 and its effect on determination of calcium concentrations.
Am. J. Physiol.
253 (Cell Physiol. 22):
C613-C618,
1987
4.
Bhoola, K. D.,
C. D. Figueroa,
and
K. Worthy.
Bioregulation of kinins: kallikreins, kininogens, and kininases.
Pharmacol. Rev.
44:
1-80,
1992[Medline].
5.
Buckley, B. J.,
Z. Mirza,
and
A. R. Whorton.
Regulation of Ca2+-dependent nitric oxide synthase in bovine aortic endothelial cells.
Am. J. Physiol.
269 (Cell Physiol. 38):
C757-C765,
1995
6.
Dantzler, W. H.,
and
S. Silbernagl.
Basic amino acid transport in renal papilla: microinfusion of Henle's loops and vasa recta.
Am. J. Physiol.
265 (Renal Fluid Electrolyte Physiol. 34):
F830-F838,
1993
7.
Di Virgilio, F.,
T. H. Steinberg,
and
S. C. Silverstein.
Inhibition of fura-2 sequestration and secretion with organic anion transport blockers.
Cell Calcium
11:
57-62,
1990[Medline].
8.
Figueroa, C. D.,
C. B. Gonzalez,
S. Grigoriev,
S. A. Abd Alla,
M. Haasemann,
K. Jarnagin,
and
W. Muller-Esterl.
Probing for the bradykinin B2 receptor in rat kidney by anti-peptide and anti-ligand antibodies.
J. Histochem. Cytochem.
43:
137-148,
1995[Abstract].
9.
Figueroa, C. D.,
A. G. MacIver,
J. C. Mackenzie,
and
K. D. Bhoola.
Localisation of immunoreactive kininogen and tissue kallikrein in the human nephron.
Histochemistry
89:
437-442,
1988[Medline].
10.
Grynkiewicz, G.,
M. Poenie,
and
R. Y. Tsien.
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
J. Biol. Chem.
260:
3440-3450,
1986
11.
Hall, J. M.
Bradykinin receptors: pharmacological properties and biological roles.
Pharmacol. Ther.
56:
131-190,
1992[Medline].
12.
Hermann, A.,
A. Braun,
C. D. Figueroa,
W. Muller-Esterl,
H. Fritz,
and
J. Rehbock.
Expression and cellular localization of kininogens in the human kidney.
Kidney Int.
50:
79-84,
1996[Medline].
13.
Kimura, K.,
M. Takagi,
T. Igari,
M. Ishii,
T. Ikeda,
and
S. Murao.
Histochemical localization of kallikrein-like Pro-Phe-Arg-naphthylester esterase activity in the rat kidney.
Histochemistry
75:
91-98,
1982[Medline].
14.
Larson, T. S.,
and
J. C. Lockhart.
Restoration of vasa recta hemodynamics and pressure natriuresis in SHR by L-arginine.
Am. J. Physiol.
268 (Renal Fluid Electrolyte Physiol. 37):
F907-F912,
1995
15.
Mattson, D. L.,
and
A. W. Cowley, Jr.
Kinin actions on renal papillary blood flow and sodium excretion.
Hypertension
21:
961-965,
1993
16.
Michell, R. H.,
C. J. Kirk,
and
M. M. Billah.
Hormonal stimulation of phosphatidylinositol breakdown, with particular reference to the hepatic effects of vasopressin.
Biochem. Soc. Trans.
7:
861-865,
1979[Medline].
17.
Moore, E. D. W.,
P. L. Becker,
K. E. Fogarty,
D. A. Williams,
and
F. S. Fay.
Ca2+ imaging in single living cells: theoretical and practical issues.
Cell Calcium
11:
157-179,
1990[Medline].
18.
Morel, N. M. L.,
P. P. Petruzzo,
H. B. Hechtman,
and
D. Shapiro.
Inflammatory agonists that increase microvascular permeability in vivo stimulate cultured pulmonary microvessel endothelial cell contraction.
Inflammation
14:
571-583,
1990[Medline].
19.
Pallone, T. L.
Vasoconstriction of outer medullary vasa recta by angiotensin II is modulated by prostaglandin E2.
Am. J. Physiol.
266 (Renal Fluid Electrolyte Physiol. 35):
F850-F857,
1994
20.
Pallone, T. L.,
J. Work,
R. L. Myers,
and
R. L. Jamison.
Transport of sodium and urea in renal outer medullary vascular bundles.
J. Clin. Invest.
93:
212-222,
1994.
21.
Proud, D.,
M. A. Knepper,
and
J. J. Pisano.
Distribution of immunoreactive kallikrein along the rat nephron.
Am. J. Physiol.
244 (Renal Fluid Electrolyte Physiol. 13):
F510-F515,
1983.
22.
Regoli, D.,
D. Jukic,
F. Gobeil,
and
N. E. Rhaleb.
Receptors for bradykinin and related kinins: a critical analysis.
Can. J. Physiol. Pharmacol.
71:
556-567,
1993[Medline].
23.
Roe, M. W.,
J. J. Lemasters,
and
B. Herman.
Assessment of fura-2 for measurements of cytosolic free calcium.
Cell Calcium
11:
63-73,
1990[Medline].
24.
Roman, R. J.,
M. L. Kaldunski,
A. G. Scicli,
and
O. A. Carretero.
Influence of kinins and angiotensin II on the regulation of papillary blood flow.
Am. J. Physiol.
255 (Renal Fluid Electrolyte Physiol. 24):
F690-F698,
1988
25.
Seino, M., K. Abe, N. Nushiro, K. Omata, Y. Kasai, and K. Yoshinaga. Contribution of bradykinin to maintenance of blood
pressure and renal blood flow in anaesthetized spontaneously
hypertensive rats. J. Hypertens. 6, Suppl. 4: S401-S403, 1988.
26.
Silldorff, E. P.,
S. Yang,
and
T. L. Pallone.
Prostaglandin E2 abrogates endothelin-induced vasoconstriction in renal outer medullary descending vasa recta of the rat.
J. Clin. Invest.
95:
2734-2740,
1995.
27.
Simson, J. A. V.,
S. S. Spicer,
J. Chao,
L. Grimm,
and
H. S. Margolius.
Kallikrein localization in rodent salivary glands and kidneys with the immunoglobulin-enzyme bridge technique.
J. Histochem. Cytochem.
27:
1567-1576,
1979[Abstract].
28.
Tsien, R.,
and
T. Pozzan.
Measurement of cytosolic free Ca2+ with quin-2.
Methods Enzymol.
172:
230-262,
1989[Medline].
29.
Turner, M. R.,
and
T. L. Pallone.
Vasopressin constricts outer medullary descending vasa recta isolated from rat kidneys.
Am. J. Physiol.
272 (Renal Physiol. 41):
F147-F151,
1997
30.
Vio, C. P.,
and
C. D. Figueroa.
Subcellular localization of renal kallikrein by ultrastructural immunocytochemistry.
Kidney Int.
28:
36-42,
1985[Medline].
31.
Vio, C. P.,
and
C. D. Figueroa.
Evidence for a stimulatory effect of high potassium diet on renal kallikrein.
Kidney Int.
31:
1327-1334,
1987[Medline].
32.
Yang, S.,
E. P. Silldorff,
and
T. L. Pallone.
Effect of norepinephrine and acetylcholine on outer medullary descending vasa recta.
Am. J. Physiol.
269 (Heart Circ. Physiol. 38):
H710-H716,
1995
This article has been cited by other articles:
![]() |
C. Cao, K. Payne, W. Lee-Kwon, Z. Zhang, S. W. Lim, J. Hamlyn, M. P. Blaustein, H. M. Kwon, and T. L. Pallone Chronic ouabain treatment induces vasa recta endothelial dysfunction in the rat Am J Physiol Renal Physiol, January 1, 2009; 296(1): F98 - F106. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cao, W. Lee-Kwon, K. Payne, A. Edwards, and T. L. Pallone Descending vasa recta endothelia express inward rectifier potassium channels Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1248 - F1255. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Fellner and W. Arendshorst Endothelin-A and -B receptors, superoxide, and Ca2+ signaling in afferent arterioles Am J Physiol Renal Physiol, January 1, 2007; 292(1): F175 - F184. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pittner, K. Rhinehart, and T. L. Pallone Ouabain modulation of endothelial calcium signaling in descending vasa recta Am J Physiol Renal Physiol, October 1, 2006; 291(4): F761 - F769. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Cowley Jr., T. Mori, D. Mattson, and A.-P. Zou Role of renal NO production in the regulation of medullary blood flow Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2003; 284(6): R1355 - R1369. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rhinehart, C. A. Handelsman, E. P. Silldorff, and T. L. Pallone ANG II AT2 receptor modulates AT1 receptor-mediated descending vasa recta endothelial Ca2+ signaling Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H779 - H789. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Pallone, Z. Zhang, and K. Rhinehart Physiology of the renal medullary microcirculation Am J Physiol Renal Physiol, February 1, 2003; 284(2): F253 - F266. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Mattson Importance of the renal medullary circulation in the control of sodium excretion and blood pressure Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2003; 284(1): R13 - R27. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, K. Rhinehart, and T. L. Pallone Membrane potential controls calcium entry into descending vasa recta pericytes Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2002; 283(4): R949 - R957. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rhinehart, Z. Zhang, and T. L. Pallone Ca2+ signaling and membrane potential in descending vasa recta pericytes and endothelia Am J Physiol Renal Physiol, October 1, 2002; 283(4): F852 - F860. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Rhinehart and T. L. Pallone Nitric oxide generation by isolated descending vasa recta Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H316 - H324. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, J. M. C. Huang, M. R. Turner, K. L. Rhinehart, and T. L. Pallone Role of chloride in constriction of descending vasa recta by angiotensin II Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2001; 280(6): R1878 - R1886. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Silldorff and T. L. Pallone Adenosine signaling in outer medullary descending vasa recta Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2001; 280(3): R854 - R861. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Pallone, E. P. Silldorff, and Z. Zhang Inhibition of calcium signaling in descending vasa recta endothelia by ANG II Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1248 - H1255. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tornel, M. I. Madrid, M. Garcia-Salom, K. J. Wirth, and F. J. Fenoy Role of Kinins in the Control of Renal Papillary Blood Flow, Pressure Natriuresis, and Arterial Pressure Circ. Res., March 17, 2000; 86(5): 589 - 595. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Praddaude, J. Marchetti, F. Alhenc-Gelas, and J.-L. Ader Dissimilar mechanisms of Ca2+ response to bradykinin in different types of juxtamedullary glomerular arterioles Am J Physiol Renal Physiol, November 1, 1999; 277(5): F697 - F705. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Pallone and J. M.-C. Huang Control of descending vasa recta pericyte membrane potential by angiotensin II Am J Physiol Renal Physiol, June 1, 2002; 282(6): F1064 - F1074. [Abstract] [Full Text] [PDF] |
||||
| ||||||||